Avastin has become the first angiogenesis inhibitor to market; it secured US FDA approval at the end of February 2004 for use as a first-line treatment for patients with metastatic colorectal cancer.
-
Avastin has become the first angiogenesis inhibitor to market; it secured US... -
Angiogenesis inhibitors are designed to stop tumours from developing a blood... -
Tumour angiogenesis. (Source: ABPI) -
Cross-section of solid tumour. (Source: ABPI) -
Roche R&D Centre, Basle. -
Drug development and approval process. -
To meet the growing demand for licensed products and new drugs coming on...
